EPW India (EPWINDIA)

Score breakdown: P/E: 0/3 · ROCE: 2/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• ROCE of 59.82% indicates strong capital efficiency, possibly reflecting a niche position or pricing power.
• Promoter holding of 71.43% aligns management interests with minority shareholders.
• Latest quarter shows profitability: ₹4 crore net profit on ₹38 crore sales, implying a ~10.5% net margin.
• Price near ₹115 is close to the 52-week low of ₹109.05, offering a potential entry point if the business stabilizes.

Concerns

• P/E of 36.94 is expensive for a business with 0.00% sales and profit growth.
• Piotroski F-score of 3/9 suggests weak financial health and poor fundamental quality.
• 52-week collapse from ₹282.05 to ₹115 indicates deteriorating market expectations.
• No dividend, no book value, no debt/equity data, and no ROE available—balance sheet risk cannot be assessed.

AI Analysis

Let's examine EPW India through the Graham lens. At ₹115, the market cap is ₹149 crore, and the stock has collapsed from ₹282 in the 52-week range. That drop alone doesn't make it a bargain. The P/E, at 36.94, is steep, especially with sales growth and profit growth both at 0.00%. I am being asked to pay a premium for stagnation. The latest quarter shows ₹38 crore in sales and ₹4 crore in net profit, offering a net margin near 10.5%, but one quarter does not establish a trend. The trailing earnings supporting the multiple are only around ₹4 crore, so any setback could hurt. ROCE of 59.82% catches my eye; that level of capital efficiency suggests a niche position or pricing power. Promoter holding of 71.43% is also encouraging—owners have skin in the game. Yet there is no dividend, no book value disclosed, no debt/equity ratio, and no ROE available. I cannot evaluate the balance sheet, and without that, Graham would call this speculation. The Piotroski F-score of 3/9 further warns of poor financial health. The 52-week fall from ₹282.05 to ₹115 means Mr. Market has been harsh; sometimes he is right. With zero growth and an expensive earnings multiple, there is no margin of safety. This looks like a potential turnaround, but the fundamentals do not yet show convincing improvement. I need consistent earnings, stronger financials, and a lower price before I commit. Patience is the investor's ally.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer